InventisBio
Dr. Jiang has over 14 years of pharmaceutical R&D experience at Schering-Plough and Merck. After returning to China, he served as a VP at ABA Chemicals in charging of R&D. Dr. Jiang received his bachelor's degree from the University of Utah and Ph.D. from the University of Wisconsin-Madison.
This person is not in any offices
InventisBio
Yifang Biotechnology (Shanghai) Co., Ltd. is an entrepreneurial biomedical company established in 2013. It is committed to the research and development of new drugs in the fields of the tumor, tumor immunity, and metabolism. The company's product pipeline includes lung cancer, breast cancer, tumor immunity, and gout, etc. Small molecule drug candidates for targeted therapy in the field, and the company is also actively developing drugs for other tumor and immune tumor targets.